Literature DB >> 19453756

Helicobacter pylori-coccoid forms and biofilm formation.

Leif Percival Andersen1, Lone Rasmussen.   

Abstract

Electron microscopic studies have shown that Helicobacter pylori occurs in three stages: spiral forms, coccoid forms and degenerative forms. The spiral forms are viable, culturable, virulent and can colonize experimental animals and induce inflammation. The coccoid forms may also be viable but are nonculturable, less virulent and are less likely to colonize and induce inflammation in experimental animals than the spiral forms. The degenerative forms are pyknotic, nonculturable, coccoid forms of dead H. pylori. These forms cannot be cultured and the cell membrane has disintegrated but gene material can be detected by PCR in water supplies. There is no substantial evidence for viable H. pylori persisting in water supplies. Epidemiological studies suggest that environmental water is a risk factor for H. pylori infection when compared with tap water, and formation of H. pylori biofilm cannot be excluded. Helicobacter pylori does not seem to take part in biofilm formation in the oral cavity even though the bacterium may be detected.

Entities:  

Mesh:

Year:  2009        PMID: 19453756     DOI: 10.1111/j.1574-695X.2009.00556.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  35 in total

1.  Peptidoglycan crosslinking relaxation promotes Helicobacter pylori's helical shape and stomach colonization.

Authors:  Laura K Sycuro; Zachary Pincus; Kimberley D Gutierrez; Jacob Biboy; Chelsea A Stern; Waldemar Vollmer; Nina R Salama
Journal:  Cell       Date:  2010-05-28       Impact factor: 41.582

2.  Mechanisms of bacterial morphogenesis: evolutionary cell biology approaches provide new insights.

Authors:  Chao Jiang; Paul D Caccamo; Yves V Brun
Journal:  Bioessays       Date:  2015-02-09       Impact factor: 4.345

Review 3.  Peptidoglycan remodeling by the coordinated action of multispecific enzymes.

Authors:  Laura Alvarez; Akbar Espaillat; Juan A Hermoso; Miguel A de Pedro; Felipe Cava
Journal:  Microb Drug Resist       Date:  2014-05-05       Impact factor: 3.431

4.  Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori.

Authors:  Marygorret Obonyo; Li Zhang; Soracha Thamphiwatana; Dissaya Pornpattananangkul; Victoria Fu; Liangfang Zhang
Journal:  Mol Pharm       Date:  2012-08-06       Impact factor: 4.939

5.  Helicobacter pylori and oral pathology: relationship with the gastric infection.

Authors:  Isabel Adler; Andrea Muiño; Silvia Aguas; Laura Harada; Mariana Diaz; Adriana Lence; Mario Labbrozzi; Juan Manuel Muiño; Boris Elsner; Alejandra Avagnina; Valeria Denninghoff
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Detection of Helicobacter pylori in oropharyngeal lymphatic tissue with real-time PCR and assessment of its carcinogenic potential.

Authors:  Petr Lukeš; Emil Pavlík; Bela Potuznikova; Eva Nartova; Eva Foltynova; Jan Plzak; Rami Katra; Ivan Sterzl; Jirina Bartunkova; Jan Betka; Jaromir Astl
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-07       Impact factor: 2.503

Review 7.  Biofilms and Helicobacter pylori: Dissemination and persistence within the environment and host.

Authors:  Steven L Percival; Louise Suleman
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

8.  Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.

Authors:  Hala El-Zimaity; Stefano Serra; Eva Szentgyorgyi; Rajkumar Vajpeyi; Amir Samani
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

Review 9.  Helicobacter pylori: a chameleon-like approach to life.

Authors:  Luigina Cellini
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 10.  Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection.

Authors:  Pradeep S Anand; Kavitha P Kamath; Sukumaran Anil
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.